Moses Zhao
Executive Director @ Cambridge Memorial Hospital
Moses Zhao is a Series B investor at Cambridge Memorial Hospital focused on Health Care and Therapeutics. Moses Zhao is the Executive Director at CMH Healthcare fund.Moses Zhao attended Hong Kong Metropolitan University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Moses Zhao invests in
Stages Moses Zhao invests in
Countries Moses Zhao invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatmentshave failed. | $25M / Series B / Dec 21, 2017 |
Co-Investors
About Cambridge Memorial Hospital
Cambridge Memorial Hospital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Moses Zhao
Executive Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Moses Zhao invest in?
Moses Zhao invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Moses Zhao last invest?
The most recent investment recorded for Moses Zhao closed in Dec 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!